TGFBR3 and cancer: Also, let‐7a may impair angiogenesis via post‐transcriptional regulation of TGFBR3. Our data likely identify a mechanistic explanation for the anti‐angiogenesis function of let‐7a and provide a potential therapeutic target for anti‐ or pro‐angiogenesis strategies in cancers and other diseases.